| BN/NHsdMcwi |
heart rate |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
heart pumping trait |
female |
93.0 days
| 14 |
serial mean |
395.0 |
beats/min |
7.0 |
26.19 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
|
|
|
65468 |
151 |
| BN/NHsdMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87.0 days-120.0 days |
4 |
|
392.72 |
beats/min |
8.3 |
16.6 |
vascular fluid filled catheter |
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
50890 |
481 |
| BN/NHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87.0 days-120.0 days |
4 |
|
-5.24 |
beats/min |
10.35 |
20.69 |
vascular fluid filled catheter |
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
50989 |
481 |
| BN/NHsdMcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
male |
87.0 days-120.0 days |
3 |
|
1.39 |
ml/min |
0.23 |
0.41 |
urine creatinine analysis |
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
51063 |
481 |
| BN/NHsdMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87.0 days-120.0 days |
3 |
|
388.81 |
beats/min |
6.13 |
10.62 |
vascular fluid filled catheter |
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
51255 |
481 |
| BN/NHsdMcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
male |
87.0 days-120.0 days |
3 |
|
0.29 |
mg/dl |
0.0 |
0.01 |
radioimmunoassay |
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
51321 |
481 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (100 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
21 |
serial mean |
132.9 |
mmHg |
3.8 |
17.41 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
|
69531 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (3 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
20 |
serial mean |
135.6 |
mmHg |
3.2 |
14.31 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
|
69539 |
151 |
| BN/NHsdMcwi |
urine sodium excretion rate |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine sodium amount |
female |
92.0 days-94.0 days |
22 |
|
0.46 |
mEq/d |
0.03 |
0.13 |
unspecified method |
|
0.0 |
|
urine sodium analysis |
umol/min |
|
69468 |
151 |
| BN/NHsdMcwi |
urine creatinine level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine creatinine amount |
female |
92.0 days-94.0 days |
25 |
|
56.4 |
mg/dl |
4.95 |
24.75 |
urine creatinine analysis |
|
0.0 |
|
|
|
|
69475 |
151 |
| BN/NHsdMcwi |
urine potassium level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine potassium amount |
female |
92.0 days-94.0 days |
22 |
|
93.4 |
mmol/l |
5.7 |
26.74 |
unspecified method |
|
0.0 |
|
urine potassium analysis |
|
|
69471 |
151 |
| BN/NHsdMcwi |
plasma creatinine level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
blood creatinine amount |
female |
92.0 days-94.0 days |
8 |
|
0.42 |
mg/dl |
0.11 |
0.31 |
plasma creatinine analysis |
|
0.0 |
|
urine potassium analysis |
umol/min |
|
69485 |
151 |
| BN/NHsdMcwi |
white blood cell count |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
leukocyte quantity |
female |
92.0 days-94.0 days |
13 |
|
0.02 |
x 1000 cells/ul |
1306.0 |
4708.85 |
isolated cell counting method |
|
0.0 |
|
|
|
|
69495 |
151 |
| BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87.0 days-120.0 days |
1 |
|
5.59 |
mmHg |
|
|
vascular fluid filled catheter |
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
50636 |
481 |
| BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87.0 days-120.0 days |
5 |
|
-7.15 |
mmHg |
2.83 |
6.32 |
vascular fluid filled catheter |
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
50812 |
481 |
| BN/NHsdMcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87.0 days-120.0 days |
2 |
|
0.26 |
mg/dl |
0.06 |
0.08 |
radioimmunoassay |
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
51179 |
481 |
| BN/NHsdMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87.0 days-120.0 days |
1 |
|
432.84 |
beats/min |
|
|
vascular fluid filled catheter |
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
51254 |
481 |
| BN/NHsdMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87.0 days-120.0 days |
9 |
|
1.23 |
mEq/d |
0.15 |
0.45 |
flame atomic emission spectrometry |
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
51276 |
481 |
| BN/NHsdMcwi |
plasma total cholesterol level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
blood cholesterol amount |
female |
92.0 days-94.0 days |
10 |
|
56.0 |
mg/dl |
2.1 |
6.64 |
plasma total cholesterol measurement test |
|
0.0 |
|
|
|
|
67289 |
151 |
| BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (3 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
19 |
serial mean |
22.0 |
mmHg |
3.0 |
13.08 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
|
|
|
67301 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 28 days) then controlled sodium content diet (8 %) (for 31 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 1.5 days) then controlled exposure to ambient light (for 12 hours) |
Cowley AW Jr, et al., Physiol Genomics 2000 Apr 27;2(3):107-15. |
arterial blood pressure trait |
male |
96.0 days
| 21 |
continuous mean |
96.0 |
mmHg |
3.0 |
13.75 |
vascular indwelling catheter method |
femoral artery |
10800.0 |
|
left femoral artery |
|
|
13275 |
229 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
21 |
serial mean |
111.8 |
mmHg |
3.9 |
17.87 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
|
69527 |
151 |
| BN/NHsdMcwi |
urine potassium excretion rate |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine potassium amount |
female |
92.0 days-94.0 days |
22 |
|
0.88 |
mEq/d |
0.06 |
0.27 |
unspecified method |
|
0.0 |
|
urine potassium analysis |
umol/min |
|
69473 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87.0 days-120.0 days |
1 |
|
112.16 |
mmHg |
|
|
vascular fluid filled catheter |
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
51830 |
481 |
| BN/NHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87.0 days-120.0 days |
3 |
|
97.79 |
mmHg |
9.11 |
15.78 |
vascular fluid filled catheter |
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
51831 |
481 |
| BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87.0 days-120.0 days |
4 |
|
-9.46 |
mmHg |
3.26 |
6.51 |
vascular fluid filled catheter |
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
50813 |
481 |
| BN/NHsdMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
female |
87.0 days-120.0 days |
3 |
|
7.64 |
ng/ml/h |
1.68 |
2.91 |
radioimmunoassay |
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
51015 |
481 |
| BN/NHsdMcwi |
plasma renin activity level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
renin activity |
male |
87.0 days-120.0 days |
1 |
|
8.99 |
ng/ml/h |
|
|
radioimmunoassay |
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
51014 |
481 |
| BN/NHsdMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87.0 days-120.0 days |
3 |
|
0.95 |
mEq/d |
0.15 |
0.26 |
flame atomic emission spectrometry |
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
51275 |
481 |
| BN/NHsdMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
female |
87.0 days-120.0 days |
9 |
|
1.05 |
mEq/d |
0.12 |
0.36 |
flame atomic emission spectrometry |
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
51528 |
481 |
| BN/NHsdMcwi |
urine sodium excretion rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
urine sodium amount |
male |
87.0 days-120.0 days |
10 |
|
1.17 |
mEq/d |
0.16 |
0.49 |
flame atomic emission spectrometry |
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
51527 |
481 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (20 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
20 |
serial mean |
118.9 |
mmHg |
4.4 |
19.68 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
|
69529 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (0.5 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
21 |
serial mean |
120.4 |
mmHg |
5.3 |
24.29 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
|
69535 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (1 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
21 |
serial mean |
128.6 |
mmHg |
4.0 |
18.33 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
|
69537 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
21 |
serial mean |
137.4 |
mmHg |
4.0 |
18.33 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
|
69545 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) then acetylcholine (0.1 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
21 |
serial mean |
138.6 |
mmHg |
3.8 |
17.41 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
|
69547 |
151 |
| BN/NHsdMcwi |
urine creatinine excretion rate |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine creatinine amount |
female |
92.0 days-94.0 days |
25 |
|
0.0 |
mg/d |
0.0 |
0.0 |
urine creatinine analysis |
|
0.0 |
|
|
mg/min |
|
69477 |
151 |
| BN/NHsdMcwi |
systolic blood pressure |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92.0 days-94.0 days |
14 |
serial mean |
110.0 |
mmHg |
3.0 |
11.22 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
|
|
|
65462 |
151 |
| BN/NHsdMcwi |
diastolic blood pressure |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92.0 days-94.0 days |
14 |
serial mean |
72.0 |
mmHg |
2.0 |
7.48 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
|
|
|
65464 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92.0 days-94.0 days |
14 |
serial mean |
89.0 |
mmHg |
2.0 |
7.48 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
|
|
|
65466 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87.0 days-120.0 days |
4 |
|
91.79 |
mmHg |
3.28 |
6.56 |
vascular fluid filled catheter |
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
52009 |
481 |
| BN/NHsdMcwi |
heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87.0 days-120.0 days |
5 |
|
375.46 |
beats/min |
8.18 |
18.29 |
vascular fluid filled catheter |
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
50889 |
481 |
| BN/NHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87.0 days-120.0 days |
1 |
|
68.68 |
beats/min |
|
|
vascular fluid filled catheter |
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
51097 |
481 |
| BN/NHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
female |
87.0 days-120.0 days |
3 |
|
-11.61 |
beats/min |
15.08 |
26.12 |
vascular fluid filled catheter |
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
51098 |
481 |
| BN/NHsdMcwi |
plasma creatinine level |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
blood creatinine amount |
female |
87.0 days-120.0 days |
3 |
|
0.3 |
mg/dl |
0.02 |
0.04 |
radioimmunoassay |
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
51322 |
481 |
| BN/NHsdMcwi |
plasma triglyceride level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
blood triglyceride amount |
female |
92.0 days-94.0 days |
7 |
|
0.72 |
mmol/l |
0.11 |
0.3 |
plasma triglyceride analysis |
|
0.0 |
|
|
|
|
67291 |
151 |
| BN/NHsdMcwi |
urine sodium level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine sodium amount |
female |
92.0 days-94.0 days |
22 |
|
100.4 |
mmol/l |
6.5 |
30.49 |
unspecified method |
|
0.0 |
|
urine sodium analysis |
|
|
69466 |
151 |
| BN/NHsdMcwi |
plasma high density lipoprotein cholesterol level |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
blood HDL cholesterol amount |
female |
92.0 days-94.0 days |
9 |
|
44.2 |
mg/dl |
2.2 |
6.6 |
plasma high-density lipoprotein-cholesterol measurement test |
|
0.0 |
|
|
|
|
69503 |
151 |
| BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
20 |
serial mean |
25.0 |
mmHg |
3.0 |
13.42 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
|
|
|
67303 |
151 |
| BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) then tactile electric shock exposure (2 %) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
92.0 days-94.0 days |
14 |
serial mean |
16.0 |
mmHg |
3.0 |
11.22 |
vascular indwelling catheter method |
left femoral artery |
0 |
|
|
|
|
66149 |
151 |
| BN/NHsdMcwi |
plasma renin activity level |
controlled sodium content diet (0.4 %) (for 35 days) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
renin activity |
female |
95.0 days
| 11 |
|
9.6 |
ng/ml/h |
1.0 |
3.32 |
ex vivo blood analysis |
|
0 |
|
|
|
|
65474 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
male |
87.0 days-120.0 days |
5 |
|
91.89 |
mmHg |
3.36 |
7.51 |
vascular fluid filled catheter |
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
52008 |
481 |
| BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
arterial blood pressure trait |
female |
87.0 days-120.0 days |
3 |
|
-2.03 |
mmHg |
7.23 |
12.52 |
vascular fluid filled catheter |
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
50637 |
481 |
| BN/NHsdMcwi |
absolute change in heart rate |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
heart pumping trait |
male |
87.0 days-120.0 days |
5 |
|
-28.94 |
beats/min |
6.27 |
14.02 |
vascular fluid filled catheter |
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
50988 |
481 |
| BN/NHsdMcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87.0 days-120.0 days |
3 |
|
0.8 |
ml/min |
0.26 |
0.45 |
urine creatinine analysis |
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
51064 |
481 |
| BN/NHsdMcwi |
creatinine clearance |
controlled sodium content diet (4 %) (between 17 and 36 days) then furosemide (10 mg/kg) and controlled sodium content diet (0.4 %) (for 2 days) |
PhysGen Renal A data |
glomerular filtration trait |
female |
87.0 days-120.0 days |
2 |
|
1.55 |
ml/min |
0.17 |
0.24 |
urine creatinine analysis |
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
51548 |
481 |
| BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (200 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
20 |
serial mean |
27.0 |
mmHg |
2.0 |
8.94 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
|
|
|
|
67299 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then angiotensin II (200 ng/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
21 |
serial mean |
139.1 |
mmHg |
3.6 |
16.5 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
|
69533 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then acetylcholine (0.1 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
21 |
serial mean |
111.3 |
mmHg |
4.6 |
21.08 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
|
69541 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then acetylcholine (0.2 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
16 |
serial mean |
118.6 |
mmHg |
3.4 |
13.6 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
|
69543 |
151 |
| BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then NG-nitroarginine methyl ester (5 mg/kg) then acetylcholine (0.2 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101.0 days-103.0 days |
17 |
serial mean |
144.9 |
mmHg |
3.1 |
12.78 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
|
|
|
|
69549 |
151 |
| BN/NHsdMcwi |
timed urine volume |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
urine output |
female |
92.0 days-94.0 days |
25 |
|
9.86 |
ml/d |
0.4 |
2.0 |
urine volume measurement method |
|
0.0 |
|
|
needs ml/d default |
|
69464 |
151 |
| BN/NHsdMcwi |
creatinine clearance |
controlled sodium content diet (0.4 %) (for 16 hours) and furosemide (10 mg/kg) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
glomerular filtration trait |
female |
92.0 days-94.0 days |
8 |
|
1.1 |
ml/min |
0.2 |
0.57 |
urine creatinine analysis |
|
0.0 |
|
|
mg/min |
|
69479 |
151 |